Add to ORKGBACKGROUND: Immunosenescence in older adults contributes to unsatisfactory immunogenicity towards influenza vaccine. Intradermal (ID) administration of influenza vaccine has been suggested to improve immunogenicity but there is no study regarding the immunogenicity of ID influenza vaccination in nursing home older adults ...postprin
Background: We aimed to compare AS03-adjuvanted inactivated trivalent influenza vaccine (TIV) with n...
Abstract: The reactogenicity and the humoral immune response to three influenza vaccines were evalua...
AbstractWe conducted a randomized, controlled, multicenter, phase II study to evaluate the immunogen...
This journal suppl. entitled: 19th Medical Research Conference; Department of Medicine, The Universi...
To determine if newer influenza vaccines can safely improve seroprotection rates of older adults, we...
To determine if newer influenza vaccines can safely improve seroprotection rates of older adults, we...
Abstract Background Although seasonal influenza vaccine is effective in the elderly, immune response...
BACKGROUND: The seasonal influenza vaccine is less effective in older people and a single dose is un...
Poster Abstract Session - Influenza Vaccines: no. 533BACKGROUND: We performed intradermal 2010/11 tr...
Abstract The reduced immunogenicity and effectiveness of influenza vaccines in subjects presenting h...
Background: The absolute degree of protection from influenza vaccines in older adults has not been s...
Objectives: Influenza disease considered to be more sever and complicated in old age persons, becaus...
Introduction: Influenza illness is an important public health problem and annual vaccination is glob...
Influenza (IV) and pneumococcal polysaccharide vaccination (PPV) may reduce hospitalization and mort...
BACKGROUND: Influenza vaccination (IV) in nursing home health care workers (nHCWs) can reduce mortal...
Background: We aimed to compare AS03-adjuvanted inactivated trivalent influenza vaccine (TIV) with n...
Abstract: The reactogenicity and the humoral immune response to three influenza vaccines were evalua...
AbstractWe conducted a randomized, controlled, multicenter, phase II study to evaluate the immunogen...
This journal suppl. entitled: 19th Medical Research Conference; Department of Medicine, The Universi...
To determine if newer influenza vaccines can safely improve seroprotection rates of older adults, we...
To determine if newer influenza vaccines can safely improve seroprotection rates of older adults, we...
Abstract Background Although seasonal influenza vaccine is effective in the elderly, immune response...
BACKGROUND: The seasonal influenza vaccine is less effective in older people and a single dose is un...
Poster Abstract Session - Influenza Vaccines: no. 533BACKGROUND: We performed intradermal 2010/11 tr...
Abstract The reduced immunogenicity and effectiveness of influenza vaccines in subjects presenting h...
Background: The absolute degree of protection from influenza vaccines in older adults has not been s...
Objectives: Influenza disease considered to be more sever and complicated in old age persons, becaus...
Introduction: Influenza illness is an important public health problem and annual vaccination is glob...
Influenza (IV) and pneumococcal polysaccharide vaccination (PPV) may reduce hospitalization and mort...
BACKGROUND: Influenza vaccination (IV) in nursing home health care workers (nHCWs) can reduce mortal...
Background: We aimed to compare AS03-adjuvanted inactivated trivalent influenza vaccine (TIV) with n...
Abstract: The reactogenicity and the humoral immune response to three influenza vaccines were evalua...
AbstractWe conducted a randomized, controlled, multicenter, phase II study to evaluate the immunogen...